INSPIREMD INC (NSPR) Fundamental Analysis & Valuation

NASDAQ:NSPR • US45779A8466

Current stock price

1.15 USD
-0.03 (-2.54%)
At close:
1.13 USD
-0.02 (-1.74%)
After Hours:

This NSPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NSPR Profitability Analysis

1.1 Basic Checks

  • In the past year NSPR has reported negative net income.
  • In the past year NSPR has reported a negative cash flow from operations.
  • In the past 5 years NSPR always reported negative net income.
  • NSPR had a negative operating cash flow in each of the past 5 years.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • NSPR has a worse Return On Assets (-70.29%) than 74.33% of its industry peers.
  • The Return On Equity of NSPR (-88.38%) is worse than 61.50% of its industry peers.
Industry RankSector Rank
ROA -70.29%
ROE -88.38%
ROIC N/A
ROA(3y)-60.16%
ROA(5y)-58.61%
ROE(3y)-75.83%
ROE(5y)-75.66%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • NSPR has a worse Gross Margin (29.50%) than 74.33% of its industry peers.
  • In the last couple of years the Gross Margin of NSPR has grown nicely.
  • NSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y55.81%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400 -500

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NSPR Health Analysis

2.1 Basic Checks

  • NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NSPR has more shares outstanding than it did 1 year ago.
  • NSPR has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • NSPR has an Altman-Z score of -5.12. This is a bad value and indicates that NSPR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -5.12, NSPR is not doing good in the industry: 73.26% of the companies in the same industry are doing better.
  • NSPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.12
ROIC/WACCN/A
WACC9.03%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 5.74 indicates that NSPR has no problem at all paying its short term obligations.
  • NSPR's Current ratio of 5.74 is fine compared to the rest of the industry. NSPR outperforms 78.61% of its industry peers.
  • A Quick Ratio of 5.42 indicates that NSPR has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 5.42, NSPR belongs to the best of the industry, outperforming 81.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.74
Quick Ratio 5.42
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. NSPR Growth Analysis

3.1 Past

  • The earnings per share for NSPR have decreased by -1.28% in the last year.
  • NSPR shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.11%.
  • The Revenue has been growing by 29.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)28.11%
Revenue growth 3Y20.2%
Revenue growth 5Y29.24%
Sales Q2Q%61.57%

3.2 Future

  • Based on estimates for the next years, NSPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.30% on average per year.
  • Based on estimates for the next years, NSPR will show a very strong growth in Revenue. The Revenue will grow by 79.37% on average per year.
EPS Next Y6.18%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.65%
Revenue Next 2Y79.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -500K -1M -1.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NSPR Valuation Analysis

4.1 Price/Earnings Ratio

  • NSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NSPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.3%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NSPR Dividend Analysis

5.1 Amount

  • No dividends for NSPR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NSPR Fundamentals: All Metrics, Ratios and Statistics

INSPIREMD INC

NASDAQ:NSPR (5/1/2026, 8:00:02 PM)

After market: 1.13 -0.02 (-1.74%)

1.15

-0.03 (-2.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength16.77
Industry Growth32.3
Earnings (Last)03-18
Earnings (Next)05-04
Inst Owners42.81%
Inst Owner Change-0.05%
Ins Owners17.48%
Ins Owner Change17.7%
Market Cap53.82M
Revenue(TTM)8.98M
Net Income(TTM)-48.79M
Analysts82.22
Price Target5.1 (343.48%)
Short Float %0.08%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.77%
Min EPS beat(2)14.53%
Max EPS beat(2)29%
EPS beat(4)3
Avg EPS beat(4)9.41%
Min EPS beat(4)-7.84%
Max EPS beat(4)29%
EPS beat(8)5
Avg EPS beat(8)1.62%
EPS beat(12)9
Avg EPS beat(12)6.9%
EPS beat(16)13
Avg EPS beat(16)11.61%
Revenue beat(2)2
Avg Revenue beat(2)29.07%
Min Revenue beat(2)17.59%
Max Revenue beat(2)40.56%
Revenue beat(4)4
Avg Revenue beat(4)19.06%
Min Revenue beat(4)3.38%
Max Revenue beat(4)40.56%
Revenue beat(8)7
Avg Revenue beat(8)11.05%
Revenue beat(12)11
Avg Revenue beat(12)10.28%
Revenue beat(16)14
Avg Revenue beat(16)8.26%
PT rev (1m)0%
PT rev (3m)25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.2%
EPS NY rev (1m)8.02%
EPS NY rev (3m)9.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.81%
Revenue NY rev (1m)-4.44%
Revenue NY rev (3m)-6.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.99
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0.19
BVpS1.18
TBVpS1.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -70.29%
ROE -88.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.5%
FCFM N/A
ROA(3y)-60.16%
ROA(5y)-58.61%
ROE(3y)-75.83%
ROE(5y)-75.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y55.81%
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 349.16%
Cap/Sales 18.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.74
Quick Ratio 5.42
Altman-Z -5.12
F-Score4
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)338.03%
Cap/Depr(5y)294.79%
Cap/Sales(3y)14.88%
Cap/Sales(5y)12.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y6.18%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.11%
Revenue growth 3Y20.2%
Revenue growth 5Y29.24%
Sales Q2Q%61.57%
Revenue Next Year64.65%
Revenue Next 2Y79.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.52%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIREMD INC / NSPR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INSPIREMD INC (NSPR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NSPR.


What is the valuation status for NSPR stock?

ChartMill assigns a valuation rating of 0 / 10 to INSPIREMD INC (NSPR). This can be considered as Overvalued.


How profitable is INSPIREMD INC (NSPR) stock?

INSPIREMD INC (NSPR) has a profitability rating of 1 / 10.


How financially healthy is INSPIREMD INC?

The financial health rating of INSPIREMD INC (NSPR) is 7 / 10.